Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Acute NK₁ receptor antagonist administration affects reward incentive anticipation processing in healthy volunteers.

Saji K, Ikeda Y, Kim W, Shingai Y, Tateno A, Takahashi H, Okubo Y, Fukayama H, Suzuki H.

Int J Neuropsychopharmacol. 2013 Aug;16(7):1461-71. doi: 10.1017/S1461145712001678. Epub 2013 Feb 13.

PMID:
23406545
2.

Modafinil augments brain activation associated with reward anticipation in the nucleus accumbens.

Funayama T, Ikeda Y, Tateno A, Takahashi H, Okubo Y, Fukayama H, Suzuki H.

Psychopharmacology (Berl). 2014 Aug;231(16):3217-28. doi: 10.1007/s00213-014-3499-0. Epub 2014 Feb 28.

PMID:
24682502
3.

Nucleus accumbens, thalamus and insula connectivity during incentive anticipation in typical adults and adolescents.

Cho YT, Fromm S, Guyer AE, Detloff A, Pine DS, Fudge JL, Ernst M.

Neuroimage. 2013 Feb 1;66:508-21. doi: 10.1016/j.neuroimage.2012.10.013. Epub 2012 Oct 13.

4.

Neural responses to monetary incentives in younger and older adults.

Spaniol J, Bowen HJ, Wegier P, Grady C.

Brain Res. 2015 Jul 1;1612:70-82. doi: 10.1016/j.brainres.2014.09.063. Epub 2014 Oct 8.

PMID:
25305570
5.

Reward Anticipation Is Differentially Modulated by Varenicline and Nicotine in Smokers.

Fedota JR, Sutherland MT, Salmeron BJ, Ross TJ, Hong LE, Stein EA.

Neuropsychopharmacology. 2015 Jul;40(8):2038-46. doi: 10.1038/npp.2015.54. Epub 2015 Mar 6.

6.

Effects of exogenous testosterone on the ventral striatal BOLD response during reward anticipation in healthy women.

Hermans EJ, Bos PA, Ossewaarde L, Ramsey NF, Fernández G, van Honk J.

Neuroimage. 2010 Aug 1;52(1):277-83. doi: 10.1016/j.neuroimage.2010.04.019. Epub 2010 Apr 14.

PMID:
20398773
7.

THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction.

Jansma JM, van Hell HH, Vanderschuren LJ, Bossong MG, Jager G, Kahn RS, Ramsey NF.

Transl Psychiatry. 2013 Feb 26;3:e234. doi: 10.1038/tp.2013.6.

8.
9.
10.

Valence-specific effects of BDNF Val66Met polymorphism on dopaminergic stress and reward processing in humans.

Peciña M, Martínez-Jauand M, Love T, Heffernan J, Montoya P, Hodgkinson C, Stohler CS, Goldman D, Zubieta JK.

J Neurosci. 2014 Apr 23;34(17):5874-81. doi: 10.1523/JNEUROSCI.2152-13.2014.

11.

Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain.

Groppe SE, Gossen A, Rademacher L, Hahn A, Westphal L, Gründer G, Spreckelmeyer KN.

Biol Psychiatry. 2013 Aug 1;74(3):172-9. doi: 10.1016/j.biopsych.2012.12.023. Epub 2013 Feb 16.

PMID:
23419544
12.

Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.

Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A.

Psychopharmacology (Berl). 2008 Mar;196(4):673-84. Epub 2007 Dec 21.

PMID:
18097655
13.

Major depressive disorder is characterized by greater reward network activation to monetary than pleasant image rewards.

Smoski MJ, Rittenberg A, Dichter GS.

Psychiatry Res. 2011 Dec 30;194(3):263-70. doi: 10.1016/j.pscychresns.2011.06.012. Epub 2011 Nov 10.

14.

Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release.

Schott BH, Minuzzi L, Krebs RM, Elmenhorst D, Lang M, Winz OH, Seidenbecher CI, Coenen HH, Heinze HJ, Zilles K, Düzel E, Bauer A.

J Neurosci. 2008 Dec 24;28(52):14311-9. doi: 10.1523/JNEUROSCI.2058-08.2008.

15.

NK1 receptor antagonism and emotional processing in healthy volunteers.

Chandra P, Hafizi S, Massey-Chase RM, Goodwin GM, Cowen PJ, Harmer CJ.

J Psychopharmacol. 2010 Apr;24(4):481-7. doi: 10.1177/0269881109103101. Epub 2009 Apr 7.

PMID:
19351798
16.

Dopaminergic modulation of the human reward system: a placebo-controlled dopamine depletion fMRI study.

da Silva Alves F, Schmitz N, Figee M, Abeling N, Hasler G, van der Meer J, Nederveen A, de Haan L, Linszen D, van Amelsvoort T.

J Psychopharmacol. 2011 Apr;25(4):538-49. doi: 10.1177/0269881110367731. Epub 2010 Jun 8.

PMID:
20530591
17.

Cortisol administration induces global down-regulation of the brain's reward circuitry.

Montoya ER, Bos PA, Terburg D, Rosenberger LA, van Honk J.

Psychoneuroendocrinology. 2014 Sep;47:31-42. doi: 10.1016/j.psyneuen.2014.04.022. Epub 2014 May 4.

PMID:
25001954
18.

Two-week administration of the combined serotonin-noradrenaline reuptake inhibitor duloxetine augments functioning of mesolimbic incentive processing circuits.

Ossewaarde L, Verkes RJ, Hermans EJ, Kooijman SC, Urner M, Tendolkar I, van Wingen GA, Fernández G.

Biol Psychiatry. 2011 Sep 15;70(6):568-74. doi: 10.1016/j.biopsych.2011.03.041. Epub 2011 May 24.

PMID:
21601833
19.

Abnormal reward system activation in mania.

Abler B, Greenhouse I, Ongur D, Walter H, Heckers S.

Neuropsychopharmacology. 2008 Aug;33(9):2217-27. Epub 2007 Nov 7.

20.

Quantifying familial influences on brain activation during the monetary incentive delay task: an adolescent monozygotic twin study.

Silverman MH, Krueger RF, Iacono WG, Malone SM, Hunt RH, Thomas KM.

Biol Psychol. 2014 Dec;103:7-14. doi: 10.1016/j.biopsycho.2014.07.016. Epub 2014 Aug 4.

Supplemental Content

Support Center